[1]
|
Marijon, E., Mirabel, M., Celermajer, D.S. and Jouven, X. (2012) Rheumatic Heart Disease. The Lancet, 379, 953-964.
https://doi.org/10.1016/S0140-6736(11)61171-9
|
[2]
|
Chugh, S., et al. (2014) Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study. Circulation, 129, 837-847. https://doi.org/10.1161/CIRCULATIONAHA.113.005119
|
[3]
|
Cagdas, M., Velibey, Y., Guvenc, T.S., Gungor, B., Guzelburc, O., Calik, N., et al. (2015) Evaluation of Atrial Electromechanical Conduction Delay in Case of Hemody-namically Insignificant Rheumatic Heart Disease: A Tissue Doppler Study. Cardiology Journal, 22, 683-690. https://doi.org/10.5603/CJ.a2015.0043
|
[4]
|
Liu, J., Wang, Y., Guo, W., Cheng, Y., Zhang, S., Wu, B., et al. (2021) Temporal Trends of Atrial Fibrillation and/or Rheumatic Heart Disease-Related Ischemic Stroke, and Anticoagu-lant Use in Chinese Population: An 8-Year Study. International Journal of Cardiology, 322, 258-264. https://doi.org/10.1016/j.ijcard.2020.08.046
|
[5]
|
Sternik, L., Luria, D., Glikson, M., Malachy, A., First, M. and Raanani, E. (2010) Efficacy of Surgical Ablation of Atrial Fibrillation in Patients with Rheumatic Heart Disease. The An-nals of Thoracic Surgery, 89, 1437-1442.
https://doi.org/10.1016/j.athoracsur.2010.01.047
|
[6]
|
Watkins, D.A., Beaton, A.Z., Carapetis, J.R., Karthikeyan, G., Mayosi, B.M., Wyber, R., et al. (2018) Rheumatic Heart Disease Worldwide: JACC Scientific Expert Panel. Journal of the American College of Cardiology, 72, 1397-1416.
https://doi.org/10.1016/j.jacc.2018.06.063
|
[7]
|
Negi, P., Mahajan, K., Rana, V., Sondhi, S., Mahajan, N., Rathour, S., et al. (2018) Clinical Characteristics, Complications, and Treatment Practices in Patients With RHD: 6-Year Results from HP-RHD Registry. Global Heart, 13, 267-274.e2.
https://doi.org/10.1016/j.gheart.2018.06.001
|
[8]
|
Noubiap, J.J., Nyaga, U.F., Ndoadoumgue, A.L., Nkeck, J.R., Ngouo, A., Bigna, J.J. (2020) Meta-Analysis of the Incidence, Prevalence, and Correlates of Atrial Fibrillation in Rheu-matic Heart Disease. Global Heart, 15, 38.
https://doi.org/10.5334/gh.807
|
[9]
|
Carabello, B.J.C. (2005) Modern Management of Mitral Stenosis. Circulation, 112, 432-437.
https://doi.org/10.1161/CIRCULATIONAHA.104.532498
|
[10]
|
Krishnamoorthy, K. and Dash, P. (2003) Predic-tion of Atrial Fibrillation in Patients with Severe Mitral Stenosis—Role of Atrial Contribution to Ventricular Filling. Scandinavian Cardiovascular Journal, 37, 344-348.
https://doi.org/10.1080/14017430310015893
|
[11]
|
Pourafkari, L., Ghaffari, S., Bancroft, G.R., Tajlil, A. and Nader, N.D. (2015) Factors Associated with Atrial Fibrillation in Rheumatic Mitral Stenosis. Asian Cardiovascular and Tho-racic Annals, 23, 17-23.
https://doi.org/10.1177/0218492314530134
|
[12]
|
Moreyra, A., Wilson, A.C., Deac, R., Suciu, C., Kostis, J.B., Ortan, F., et al. (1998) Factors Associated with Atrial Fibrillation in Patients with Mitral Stenosis: A Cardiac Catheteriza-tion Study. American Heart Journal, 135, 138-145.
https://doi.org/10.1016/S0002-8703(98)70354-0
|
[13]
|
Li, Q., Wu, H., Yue, W., Dai, Q., Liang, H., Bian, H., et al. (2017) Prevalence of Stroke and Vascular Risk Factors in China: A Nationwide Community-Based Study. Scientific Re-ports, 7, Article No. 6402.
https://doi.org/10.1038/s41598-017-06691-1
|
[14]
|
Diker, E., Aydogdu S, Ozdemir M, Kural T, Polat K, Cehreli S, et al. (1996) Prevalence and Predictors of Atrial Fibrillation in Rheumatic Valvular Heart Disease. The American Journal of Cardiology, 77, 96-98.
https://doi.org/10.1016/S0002-9149(97)89145-X
|
[15]
|
Sims, J. and Roberts, W. (2006) Comparison of Findings in Patients with versus without Atrial Fibrillation Just before Isolated Mitral Valve Replacement for Rheumatic Mitral Ste-nosis (with or without Associated Mitral Regurgitation). The American Journal of Cardiology, 97, 1035-1038. https://doi.org/10.1016/j.amjcard.2005.11.023
|
[16]
|
Unverferth, D., Fertel, R.H., Unverferth, B.J. and Leier, C.V. (1984) Atrial Fibrillation in Mitral Stenosis: Histologic, Hemodynamic and Metabolic Factors. International Journal of Cardiology, 5, 143-154.
https://doi.org/10.1016/0167-5273(84)90137-2
|
[17]
|
Ozaydin, M., Turker, Y., Varol, E., Alaca, S., Erdogan, D., Yilmaz, N., et al. (2010) Factors Associated with the Development of Atrial Fibrillation in Patients with Rheumatic Mitral Stenosis. The International Journal of Cardiovascular Imaging, 26, 547-552. https://doi.org/10.1007/s10554-010-9609-0
|
[18]
|
Alessandri, N., Tufano, F., Petrassi, M., Alessandri, C., Di Cris-tofano, C., Della Rocca, C., et al. (2009) Atrial Fibrillation in Pure Rheumatic Mitral Valvular Disease Is Expression of an Atrial Histological Change. European Review for Medical and Pharmacological Sciences, 13, 431-442.
|
[19]
|
Aviles, R., Martin, D.O., Apperson-Hansen, C., Houghtaling, P.L., Rautaharju, P., Kronmal, R.A., et al. (2003) Inflammation as a Risk Factor for Atrial Fibrillation. Circulation, 108, 3006-3010.
https://doi.org/10.1161/01.CIR.0000103131.70301.4F
|
[20]
|
Chiu-Braga, Y., Hayashi, S.Y., Schafranski, M. and Messias-Reason, I.J. (2006) Further Evidence of Inflammation in Chronic Rheumatic Valve Disease (CRVD): High Levels of Advanced Oxidation Protein Products (AOPP) and High Sensitive C-Reactive Protein (hs-CRP). International Journal of Cardiology, 109, 275-276.
https://doi.org/10.1016/j.ijcard.2005.04.030
|
[21]
|
Gölbasi, Z., Uçar, Ö., Keles, T., Sahin, A., Çagli, K., Çamsari, A., et al. (2002) Increased Levels of High Sensitive C-Reactive Protein in Patients with Chronic Rheumatic Valve Disease: Evidence of Ongoing Inflammation. European Journal of Heart Failure, 4, 593-595. https://doi.org/10.1016/S1388-9842(02)00102-2
|
[22]
|
Probst, P., Goldschlager, N. and Selzer, C. (1973) Left Atri-al Size and Atrial Fibrillation in Mitral Stenosis: Factors Influencing Their Relationship. Circulation, 48, 1282-1287. https://doi.org/10.1161/01.CIR.48.6.1282
|
[23]
|
Yetkin, E., Erbay, A.R., Ileri, M., Turhan, H., Balci, M., Cehreli, S., et al. (2001) Levels of Circulating Adhesion Molecules in Rheumatic Mitral Stenosis. American Journal of Cardiology, 88, 1209-1211.
https://doi.org/10.1016/S0002-9149(01)02067-7
|